Riverhead Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $961K | Sell |
12,050
-9,200
| -43% | -$734K | 0.04% | 501 |
|
|
2019
Q2 | $1.66M | Sell |
21,250
-10,500
| -33% | -$820K | 0.06% | 378 |
|
|
2019
Q1 | $3.73M | Sell |
31,750
-20,600
| -39% | -$2.42M | 0.15% | 190 |
|
|
2018
Q4 | $5.7M | Buy |
52,350
+3,600
| +7% | +$392K | 0.26% | 92 |
|
|
2018
Q3 | $6.23M | Buy |
48,750
+12,850
| +36% | +$1.64M | 0.23% | 120 |
|
|
2018
Q2 | $4.06M | Buy |
35,900
+7,500
| +26% | +$849K | 0.16% | 179 |
|
|
2018
Q1 | $3.19M | Buy |
28,400
+20,900
| +279% | +$2.35M | 0.13% | 209 |
|
|
2017
Q4 | $1.11M | Buy |
7,500
+2,870
| +62% | +$425K | 0.05% | 404 |
|
|
2017
Q3 | $543K | Sell |
4,630
-14,995
| -76% | -$1.76M | 0.03% | 576 |
|
|
2017
Q2 | $2.55M | Sell |
19,625
-6,661
| -25% | -$864K | 0.13% | 207 |
|
|
2017
Q1 | $3.56M | Sell |
26,286
-11,114
| -30% | -$1.5M | 0.2% | 156 |
|
|
2016
Q4 | $5.36M | Buy |
37,400
+5,119
| +16% | +$734K | 0.33% | 67 |
|
|
2016
Q3 | $3.81M | Buy |
32,281
+19,301
| +149% | +$2.28M | 0.25% | 120 |
|
|
2016
Q2 | $219K | Sell |
12,980
-47,895
| -79% | -$808K | 0.01% | 868 |
|
|
2016
Q1 | $6.78M | Buy |
60,875
+34,883
| +134% | +$3.89M | 0.1% | 273 |
|
|
2015
Q4 | $4.07M | Buy |
25,992
+23,492
| +940% | +$3.68M | 0.06% | 375 |
|
|
2015
Q3 | $328K | Buy |
+2,500
| New | +$328K | 0.01% | 618 |
|